Clinical Trials
2 trialsNCT07224776 2026-05-18
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Brigham and Women's Hospital
Phase 1 Not yet recruiting
NCT07561957 2026-05-01
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
St. James's Hospital, Ireland
Phase NA Recruiting